CIK 0001798749 · <br>Emerging growth company
Jade Biosciences, Inc.
Sign in to watch- Ticker
- JBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831377888
- Phone
- (781) 312-3013
- Business address
- 221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- Aerovate Therapeutics, Inc.
- DEFA14A Proxy Proxy Materials
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- POS EX Other Post-effective Amendment
- POS EX Other Post-effective Amendment
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- 8-A12B/A Other Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
Page 1 of 5 · 87 filings